Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)
Brazil flag Brazil · Delayed Price · Currency is BRL
618.71
+38.45 (6.63%)
At close: Dec 5, 2025

Vertex Pharmaceuticals Ratios and Metrics

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
625,501641,418508,757391,882311,089319,160
Upgrade
Market Cap Growth
-5.99%26.07%29.82%25.97%-2.53%41.02%
Upgrade
Enterprise Value
570,428582,946446,243344,587277,190290,055
Upgrade
Last Close Price
618.71617.48495.88382.28309.16305.79
Upgrade
PE Ratio
31.94-28.9722.3123.8422.66
Upgrade
PS Ratio
10.019.4110.628.307.379.90
Upgrade
PB Ratio
6.786.325.965.335.537.08
Upgrade
P/TBV Ratio
7.437.156.706.076.428.44
Upgrade
P/FCF Ratio
35.17-31.4218.8923.1820.53
Upgrade
P/OCF Ratio
31.57-29.6417.9521.1218.89
Upgrade
EV/Sales Ratio
8.998.559.327.306.579.00
Upgrade
EV/EBITDA Ratio
21.5120.5920.5414.4012.3817.66
Upgrade
EV/EBIT Ratio
23.2321.4521.3514.8912.7818.29
Upgrade
EV/FCF Ratio
32.07-27.5616.6120.6618.66
Upgrade
Debt / Equity Ratio
0.110.110.050.070.100.11
Upgrade
Debt / EBITDA Ratio
0.370.370.180.200.240.30
Upgrade
Debt / FCF Ratio
0.55-0.240.230.400.32
Upgrade
Asset Turnover
0.500.490.480.570.600.62
Upgrade
Inventory Turnover
4.105.317.388.878.9710.62
Upgrade
Quick Ratio
1.842.173.604.464.044.02
Upgrade
Current Ratio
2.362.693.994.834.464.33
Upgrade
Return on Equity (ROE)
22.31%-3.15%22.99%27.67%24.93%36.71%
Upgrade
Return on Assets (ROA)
12.04%12.14%13.17%17.33%19.32%19.02%
Upgrade
Return on Capital (ROIC)
15.51%15.03%16.22%21.15%23.51%23.29%
Upgrade
Return on Capital Employed (ROCE)
22.30%23.20%22.50%28.40%34.50%30.90%
Upgrade
Earnings Yield
3.13%-0.52%3.45%4.48%4.20%4.41%
Upgrade
FCF Yield
2.84%-0.76%3.18%5.29%4.31%4.87%
Upgrade
Buyback Yield / Dilution
-0.11%1.00%-0.54%0.31%1.33%-1.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.